Christine Paik is an associate in Weil’s Technology & IP Transactions practice and is based in New York. Ms. Paik participates in the representation of Firm clients in a variety of industries in matters relating to the licensing, acquisition, development, sale, use and commercial exploitation of intellectual property and technology. She has experience in private equity, M&A, financing and other corporate transactions, such as corporate divestitures and spin-outs, as well as in stand-alone intellectual property and technology transactions, including licensing and servicing arrangements.
Ms. Paik has been part of the teams advising on the technology and intellectual property aspects of the following matters:
- Sanofi in its $25 billion exchange of Merial, its animal health business, for the consumer healthcare business of Boehringer Ingelheim GmbH and in its $4.8 billion acquisition of Ablynx NV.
- General Electric Capital Corporation in its $6.9 billion sale of its United States, Mexico, Australia and New Zealand fleet businesses to Element Financial Corporation.
- Gurnet Point Capital in its up to $504 million take-private of Corium International, Inc.
- Westinghouse Electric Company, LLC in its $4.6 billion sale of substantially all of its global business to Brookfield Business Partners L.P.
- ENGIE North America Inc. (f/k/a GDF SUEZ Energy North America, Inc.) in its $1.2 billion sale of FirstLight Power Resources Holdings, Inc. to Public Sector Pension Investment Board and the $3.3 billion sale (and related reorganization) of its portfolio of electric generating plants in Texas, New England, and the Mid-Atlantic, to Dynegy Inc.
- General Electric Company in its $3.4 billion sale of GE Water to SUEZ.
- Adobe Systems Inc. in its $540 million acquisition of TubeMogul Inc.
- WPEngine, Inc. in the $250 million sale of a majority stake to Silver Lake Partners.
- Providence Equity Partners in its growth equity investment in TAIT, LLC (f/k/a TAIT Towers Inc.).
- Eli Lilly and Company in its $7.9 billion exchange of its approximately 82% remaining interest in Elanco Animal Health Incorporated for Lilly common shares held by its shareholders.
- Discovery, Inc. in its joint venture with Magnolia, the home and lifestyle brand led by Chip and Joanna Gaines.
- Antin Infrastructure Partners in its acquisition of FirstLight Fiber.
- OMERS Private Equity in its acquisition of Inmar, Inc.
- Reorg Research, Inc. (at the time a portfolio company of Susquehanna Growth Equity) in its sale to Warburg Pincus.
Ms. Paik is involved with Weil’s Pro Bono program, having done work on behalf of Debra of America (The Dystrophic Epidermolysis Bullosa Research Association of America) and the Minds Over Matter Foundation. She was the recipient of the Weil Pro Bono Service Award in 2014 and the New York State Bar Association Empire State Counsel Award.
Ms. Paik received her J.D. from the University of Pennsylvania Law School where she was a Sharswood Scholar, an Associate Editor of the University of Pennsylvania Journal of Business Law and East Asia Law Review, and a board member of Penn Law in the Arts and the Asian Pacific American Law Students Association. She has also received a Certificate in Business and Public Policy from the Wharton School of the University of Pennsylvania.